Status:
UNKNOWN
An Online Intervention to Address Barriers to IBD Medication Adherence
Lead Sponsor:
University College, London
Conditions:
Inflammatory Bowel Disease (IBD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background Inflammatory Bowel Disease (IBD) is a group of lifelong and relapsing inflammatory conditions that usually affect the colon and the small intestine. Between 30 to 45% of patients with IBD d...
Eligibility Criteria
Inclusion
- Age 18 or over.
- Diagnosis of IBD (Crohn's Disease or Ulcerative Colitis or Indeterminate Colitis).
- Currently prescribed one or more of the following medications for IBD: azathioprine, mesalazine, and adalimumab.
Exclusion
- We will exclude people who are for any reason unable to make an informed decision about taking part and people who do not wish to complete follow-up questionnaires.
- People who declare that they do not understand written English. This is a pilot feasibility study that aims to assess the effectiveness and acceptability of an online CBT based intervention in English.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT01852097
Start Date
May 1 2013
End Date
January 1 2014
Last Update
May 13 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.